Grantham, Mayo, Van Otterloo & Co (GMO)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $339K | Sell |
|
|||||
|
2024
Q2 | $33.4M | Sell |
|
|||||
|
2024
Q1 | $34.3M | Sell |
|
|||||
|
2023
Q4 | $34.2M | Sell |
|
|||||
|
2023
Q3 | $35.3M | Sell |
|
|||||
|
2023
Q2 | $26.7M | Buy |
|
|||||
|
2023
Q1 | $28.7M | Sell |
|
|||||
|
2022
Q4 | $34.2M | Buy |
|
|||||
|
2022
Q3 | $26.7M | Sell |
|
|||||
|
2022
Q2 | $26.1M | Sell |
|
|||||
|
2022
Q1 | $32.6M | Buy |
|
|||||
|
2021
Q4 | $22.2M | Sell |
|
|||||
|
2021
Q3 | $27.3M | Buy |
|
|||||
|
2021
Q2 | $25.3M | Buy |
|
|||||
|
2021
Q1 | $23M | Buy |
|
|||||
|
2020
Q4 | $17.5M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $231K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $897K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $542K | Sell |
|
|||||
|
2016
Q3 | $15.5M | Buy |
|
|||||
|
2016
Q2 | $14.4M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $598K | Sell |
|
|||||
|
2014
Q1 | $708K | Buy |
|